Novartis (NYSE:NVS)

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

During the presidential campaign of 2015–2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Spending on pharmaceuticals when the population ...
Read Full Story »

Why Novartis Is Moving to Acquire Advanced Accelerator Applications

Advanced Accelerator Applications S.A. (NASDAQ: AAAP) shares made a run early on Monday after it came public that Novartis A.G. (NYSE: NVS) plans to buy the company. This transaction would ...
Read Full Story »

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

The bull market is now closer to nine years old than it is eight, and the great stock market rally of 2017 has continued to amaze skeptics and bulls alike. ...
Read Full Story »

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Merrill Lynch recently released its September RIC Report, noting key strategy views and showing many sector views. One such view from the firm was that health care stocks are currently ...
Read Full Story »

Why Conatus Pharma Wins With Newest Licensing Agreement

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) saw its shares make a handy gain on Friday after the firm announced an exclusive license agreement with Novartis A.G. (NYSE: NVS). Specifically, the firm ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BHP Billiton, Capital One, Chemours, Constellation Brands, Novartis, Teradyne, Weyerhaeuser and More

Stocks were indicated to open marginally higher on Wednesday after a day off and after a strong Dow rally on Monday. Nasdaq stocks were also indicated higher on Wednesday despite ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chevron, Novartis, Randgold, Urban Outfitters, Vodafone and Many More

Stocks were initially down by a miniscule amount in early trading indications on Wednesday, but an incredibly strong ADP payrolls gain put stocks marginally higher. The markets also had edged ...
Read Full Story »
dividends

UBS Makes First Big 2017 Addition to Dividend Rulers Stocks List

With earnings reporting mostly complete, investors are turning their eyes toward the rest of the first quarter, and how it likely is shaping up. Things are looking positive as fourth-quarter ...
Read Full Story »
Prescription drugs

Conatus More Than Doubles on Key License Collaboration Agreement

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) saw its shares more than double early on Tuesday after the company reported an exclusive collaboration and license agreement for its cirrhosis treatment. Specifically, the ...
Read Full Story »
Stock Price

FitBit, Gilead Sciences in Thursday’s 52-Week Low Club

December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Stock Price

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Medicine pills

Top 5 Jefferies Big Pharma Stock Picks for Q4

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »
Prescription drugs

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Health care has lagged the top sectors in the S&P 500 over the past year, but it is starting to catch up and some nice moves in the big pharmaceutical ...
Read Full Story »
automatic inspection machine

PDL’s Next Acquisition Target Focus Is on Hypertension

PDL BioPharma Inc. (NASDAQ: PDLI) has now shown where its next revenue stream will be coming from. The company announced on Tuesday that it has committed to an equity investment ...
Read Full Story »